创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

PENG Hengying, LIU Jihua. Advances in Research on Intestinal Flora in the Pathogenesis and Treatment of Inflammatory Bowel Disease[J]. Progress in Pharmaceutical Sciences, 2021, 45(8): 627-636.
Citation: PENG Hengying, LIU Jihua. Advances in Research on Intestinal Flora in the Pathogenesis and Treatment of Inflammatory Bowel Disease[J]. Progress in Pharmaceutical Sciences, 2021, 45(8): 627-636.

Advances in Research on Intestinal Flora in the Pathogenesis and Treatment of Inflammatory Bowel Disease

  • Inflammatory bowel disease(IBD) is a chronic disease characterized by intestinal inflammation and mucosal damage, including mainly Crohn,s disease(CD) and ulcerative colitis(UC), still with unknown etiopathogenesis. Current studies have found that its pathogenesis is closely related to the host,s genetic susceptibility, intestinal flora dysbiosis, intestinal mucosal barrier damage and intestinal mucosal immune abnormalities. In this review, the related research progress of the mechanism of IBD, the structure of patients, intestinal flora and treatment methods are summarized, in an attempt to provide some reference for the development of new therapies and new drugs against inflammatory bowel disease in the future.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return